New Vaccine Development: Establishing Priorities: Volume I, Diseases of Importance in the United States

Questions? Call 800-624-6242

About | Ordering | New

LoginRegister

| Items in cart [0]

Rights & Permissions

Free PDF Access

Free Resources

Related Titles

New Vaccine Development: Establishing Priorities: Volume I, Diseases of Importance in the United States (1985)
Board on Population Health and Public Health Practice (BPH)

Citation Manager Export the bibliographic data for this book in your chosen format
Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web.
Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book.
Reference Finder Paste in your own text to find books that relate to your topic.

Citation Manager

. "Appendix C: Prospects for Immunizing Against Bordetella pertussis." New Vaccine Development: Establishing Priorities: Volume I, Diseases of Importance in the United States. Washington, DC: The National Academies Press, 1985.

Please select a format:

Page
182


E-mail Share on facebook Facebook Share on delicious Delicious Share on stumbleupon Stumble Share on twitter Twitter More Sharing ServicesMore

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.

New Vaccine Development Establishing Priorities, Volume I: Diseases of Importance in the United States

References

American Academy of Pediatrics. 1982. Pertussis. Pp. 198–202 in Report of the Committee on Infectious Diseases. 19th Edition. American Academy of Pediatrics, Evanston, Ill.

Broome, C. 1984. Epidemiology of pertussis: risks and benefits of the current vaccination program. Pp. 158–160 in Microbiology 1984, L.Leivy and D.Schlessinger, eds. Washington, D.C.: American Society for Microbiology.

Centers for Disease Control. 1982. Pertussis surveillance 1979–1981. Morbid. Mortal. Weekly Report 31(25):333–336.

Centers for Disease Control. 1984. Pertussis surveillance 1983. Morbid. Mortal. Weekly Report 32:682.

Cody, C.L., L.J.Baraff, J.D.Cherry, S.M.Marcy, and C.R.Manclark. 1981. Nature and rates of adverse reactions associated with DPT and DT immunizations in infants and children. Pediatrics 68(5):650–660.

Fulginiti, V.A. 1984. Pertussis disease, vaccine and controversy. JAMA 251(2):251.

Hinman, A.R., and J.P.Koplan. 1984. Pertussis and pertussis vaccine: reanalysis of benefits, risks, and costs. JAMA 251(23):3109–3113.

Kanai, K. 1980. Japan’s experience in pertussis epidemiology and vaccination in the past 30 years. Japan J. Med. Sci. Biol. 33(3):107–143.

Medical Research Council. 1956. Vaccination against whooping cough: relation between protection in children and results in laboratory tests. Brit. Med. J. 2:454–462.

Miller, D.L., E.M.Ross, R.Alderslade, M.H.Bellman, and N.S.Rawson. 1981. Pertussis immunization and serious acute neurological illness in children. Brit. Med. J. 282(6276):1595–1599.

Mortimer, E.A. 1982. Pertussis. Pp. 393–402 in Bacterial infections of Humans, A.S.Evans and H.A.Feldman, eds. New York: Plenum.

Robbins, J.B. 1984. Towards a new vaccine for pertussis. Pp. 176–183 in Microbiology 1984, L.Leivy and D.Schlessinger, eds. Washington, D.C.: American Society for Microbiology.

Sato, Y., K.Izumiya, H.Sato, J.Cowell, and C.Manclark. 1981. Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis. Infect. Immun. 31(3):1223–1231.